Effective Technique Using Combined CO2 Laser and Pulsed Dye Laser for Facial Angiofibromas Management in Tuberous Sclerosis.

Q3 Medicine
Case Reports in Dermatological Medicine Pub Date : 2024-09-16 eCollection Date: 2024-01-01 DOI:10.1155/2024/9775613
Giuseppe Lodi, Giovanni Cannarozzo, Irene Fusco, Tiziano Zingoni, Elena Campione, Mario Sannino
{"title":"Effective Technique Using Combined CO<sub>2</sub> Laser and Pulsed Dye Laser for Facial Angiofibromas Management in Tuberous Sclerosis.","authors":"Giuseppe Lodi, Giovanni Cannarozzo, Irene Fusco, Tiziano Zingoni, Elena Campione, Mario Sannino","doi":"10.1155/2024/9775613","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Facial angiofibromas (FAs) are a dermatological characteristic which are typically linked to tuberous sclerosis (TS).</p><p><strong>Aim: </strong>We discuss our experience, highlighting a rare occurrence of multiple FAs in a young patient, successfully treated with ablative CO<sub>2</sub> laser combined with PDL therapy.</p><p><strong>Methods: </strong>A 23-year-old male patient affected by TS who presents multiple erythematous and colored papules/nodules located on the face, mainly concentrated around nose, perinasal area, cheeks, and chin area, was treated with a combination of ablative CO<sub>2</sub> laser and a pulsed dye laser. The patient underwent 3 sessions of combined treatment with CO<sub>2</sub> and pulsed dye laser. The intralesional dye laser treatment was administered immediately after the CO<sub>2</sub> laser session. The time interval between the combined laser treatments was approximately two months.</p><p><strong>Results: </strong>After 4 months from the last laser treatment session, most of the facial erythematous and protruding lesions had improved. Following these procedures, the patient did not experience complications or severe adverse reaction.</p><p><strong>Conclusion: </strong>The combined use of the CO<sub>2</sub> and dye laser has been proved to be a safe and effective treatment for multiple FAs in the young patient affected by tuberous sclerosis.</p>","PeriodicalId":9630,"journal":{"name":"Case Reports in Dermatological Medicine","volume":"2024 ","pages":"9775613"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11419839/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Dermatological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/9775613","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Facial angiofibromas (FAs) are a dermatological characteristic which are typically linked to tuberous sclerosis (TS).

Aim: We discuss our experience, highlighting a rare occurrence of multiple FAs in a young patient, successfully treated with ablative CO2 laser combined with PDL therapy.

Methods: A 23-year-old male patient affected by TS who presents multiple erythematous and colored papules/nodules located on the face, mainly concentrated around nose, perinasal area, cheeks, and chin area, was treated with a combination of ablative CO2 laser and a pulsed dye laser. The patient underwent 3 sessions of combined treatment with CO2 and pulsed dye laser. The intralesional dye laser treatment was administered immediately after the CO2 laser session. The time interval between the combined laser treatments was approximately two months.

Results: After 4 months from the last laser treatment session, most of the facial erythematous and protruding lesions had improved. Following these procedures, the patient did not experience complications or severe adverse reaction.

Conclusion: The combined use of the CO2 and dye laser has been proved to be a safe and effective treatment for multiple FAs in the young patient affected by tuberous sclerosis.

使用二氧化碳激光和脉冲染料激光联合疗法治疗结节性硬化症面部血管纤维瘤的有效技术
背景:面部血管纤维瘤(FA)是一种皮肤病特征,通常与结节性硬化症(TS)有关。目的:我们讨论了我们的经验,重点是一名年轻患者罕见的多发性FA,该患者成功接受了CO2激光烧蚀联合PDL治疗:一名 23 岁的男性 TS 患者,面部出现多个红斑和彩色丘疹/结节,主要集中在鼻子周围、肛周、脸颊和下巴部位。患者接受了 3 次二氧化碳激光和脉冲染料激光联合治疗。二氧化碳激光治疗结束后立即进行染料激光治疗。联合激光治疗的间隔时间约为两个月:结果:距离最后一次激光治疗 4 个月后,大部分面部红斑和突出皮损都得到了改善。治疗后,患者没有出现并发症或严重不良反应:事实证明,联合使用二氧化碳激光和染料激光可安全有效地治疗结节性硬化症年轻患者的多发性FA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
24
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信